Julie Powell Selected Research

Hemangioma (Angioma)

1/2021	Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma.
1/2021	Off-Label Use and Safety of Drug Use in Vascular Anomalies.
5/2020	Management of infantile hemangiomas during the COVID pandemic.
1/2020	Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
11/2018	Localized infantile hemangiomas of the face and scalp: Predilection for the midline and periorbital and perioral skin.
7/2018	Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
9/2016	Topical Timolol Maleate Treatment of Infantile Hemangiomas.
4/2016	Rebound Growth of Infantile Hemangiomas After Propranolol Therapy.
2/2015	A randomized, controlled trial of oral propranolol in infantile hemangioma.
9/2013	Late rebound of infantile hemangioma after cessation of oral propranolol.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Powell Research Topics

Disease

21	Hemangioma (Angioma) 01/2021 - 01/2006
5	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 01/2022 - 03/2016
5	Hemorrhage 11/2021 - 03/2012
2	Blister (Bulla) 01/2022 - 11/2006
2	Wounds and Injuries (Trauma) 01/2022 - 07/2013
2	Vascular Malformations 11/2021 - 09/2010
2	Stroke (Strokes) 01/2020 - 01/2013
2	Vascular Diseases (Vascular Disease) 03/2015 - 10/2014
2	Hypotension (Low Blood Pressure) 02/2015 - 06/2011
2	Necrosis 01/2013 - 01/2006
2	Nevus (Nevi) 11/2012 - 08/2011
2	Neoplasms (Cancer) 01/2006 - 11/2005
1	Skin Diseases (Skin Disease) 01/2022
1	Pain (Aches) 11/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Ischemic Stroke 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Transient Ischemic Attack 01/2020
1	Bullous Pemphigoid (Pemphigoid) 05/2019
1	Atopic Dermatitis (Atopic Eczema) 02/2019
1	Food Hypersensitivity (Food Allergy) 02/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Infections 05/2018
1	Stiff Skin Syndrome 01/2018
1	Thinness 09/2016
1	Hypoglycemia (Reactive Hypoglycemia) 02/2015
1	Bradycardia 02/2015
1	Bronchial Spasm 02/2015
1	Body Weight (Weight, Body) 02/2015
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 07/2014
1	Vulvar Lichen Sclerosus 07/2014
1	Chronic Disease (Chronic Diseases) 07/2014
1	Aortic Coarctation 01/2013
1	Paresis (Hemiparesis) 01/2013
1	Eye Abnormalities (Eye Abnormality) 01/2013
1	Tuberous Sclerosis (Bourneville's Disease) 11/2012
1	Hamartoma 11/2012
1	Melanoma (Melanoma, Malignant) 08/2011
1	Erythema 03/2009
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 03/2008
1	Colitis 03/2008
1	Nephrocalcinosis 01/2006
1	Hypercalcemia (Milk Alkali Syndrome) 01/2006
1	Down Syndrome (Down's Syndrome) 11/2005
1	Hyperplasia 07/2005
1	Hemoptysis 07/2005
1	Gastrointestinal Hemorrhage (Hematochezia) 07/2005

Drug/Important Bio-Agent (IBA)

17	Propranolol (Inderal)FDA LinkGeneric 01/2021 - 03/2011
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2019 - 01/2006
3	Keratin-14 (Keratin 14)IBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2009
2	Keratin-5 (Keratin 5)IBA 01/2022 - 10/2020
2	Sirolimus (Rapamycin)FDA Link 11/2021 - 07/2018
2	SolutionsIBA 01/2021 - 02/2015
2	Dihydrotachysterol (AT 10)IBA 11/2018 - 03/2012
2	CollagenIBA 03/2015 - 10/2014
2	InterferonsIBA 06/2012 - 01/2006
1	Hemostatics (Antihemorrhagics)IBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	EnzymesIBA 02/2019
1	Terbinafine (Lamisil)FDA LinkGeneric 05/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	Timolol (Blocadren)FDA LinkGeneric 09/2016
1	Keratins (Keratin)IBA 03/2016
1	trimethyloxamine (trimethylamine N-oxide)IBA 03/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 07/2014
1	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 07/2014
1	Becaplermin (PDGF-BB)FDA Link 07/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2013
1	Morphine (MS Contin)FDA LinkGeneric 07/2013
1	HydrogelsIBA 07/2013
1	trans-crotonin (CTN)IBA 11/2012
1	SteroidsIBA 06/2012
1	Vincristine (Oncovin)FDA LinkGeneric 06/2012
1	Hemoglobins (Hemoglobin)IBA 03/2012
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 03/2012
1	Tranexamic Acid (AMCA)FDA Link 03/2012
1	Prednisone (Sone)FDA LinkGeneric 11/2011
1	Proteins (Proteins, Gene)FDA Link 08/2011
1	Imiquimod (Aldara)FDA LinkGeneric 03/2009
1	Interferon-alpha (Interferon Alfa)IBA 03/2009
1	Cantharidin (Cantharides)IBA 11/2006
1	Pamidronate (Aredia)FDA LinkGeneric 01/2006
1	Biomarkers (Surrogate Marker)IBA 01/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2006
1	Furosemide (Lasix)FDA LinkGeneric 01/2006
1	Periodic AcidIBA 07/2005

Therapy/Procedure

15	Therapeutics 11/2021 - 07/2005
1	Gastrostomy 01/2019
1	Duration of Therapy 09/2016
1	Off-Label Use 09/2016
1	Pain Management 07/2013
1	Dye Lasers 07/2013
1	Blood Transfusion (Blood Transfusions) 06/2012
1	Skin Transplantation (Skin Grafting) 03/2008
1	Colonic Pouches (S Pouch) 03/2008
1	Drug Therapy (Chemotherapy) 01/2006
1	Chemoradiotherapy 11/2005